Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) shares fell on Wednesday Dec 28 with lower trade volume than normal after more analysts initiated coverage on the stock.
Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.
The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.
Analysts at Janney Montgomery Scott initiated coverage on Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) stock, starting the company at Neutral. Janney Montgomery Scott currently has a rating of Neutral on the shares. The one-year price target of $18.79 is higher than the opening price of $13.15, resulting a fair amount of other analysts to issue statements on the stock in recent days. Looking back over the last 52 weeks, Impax Laboratories Inc. stock has a high of $44.26. Changes in price targets are not unusual as analysts and brokerage firms will re periodic updates after initiating coverage,.
Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) shares last traded at $13.20, which represents a decrease of $0.05 per share or -0.38% compared to the previous closing price. Opening at $13.15, they fluctuated from $13.15 and $13.35 throughout the day.
Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) currently has a market cap of 941.56M.
Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) Average Daily Trading Volume
The stock’s average daily volume is 1,308,210 shares out of a total float 60,347,000 and some 59,475 shares traded hands yesterday, below the average. Trading volume is likely to increase in the next few days as momentum traders often use upticks in trading volume to identify substantial volume growth or circulation by institutional investors.
However, just a day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to look for institutional sponsorship as an indicator that financial institutions are moving forward.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Professional investors such as these have teams of analysts that investigate thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.
With that in mind, Janney Montgomery Scott (Impax Laboratories Inc.: NASDAQ) now has a 50-day MA of $13.97 and 200-day MA of $23.07. It has traded in a 52-week range between $12.27 – 44.26 and today’s last price is 70.18%% lower than the 52 week high of $44.26.
Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors watch for companies that have increased their earnings by at least 25% for a 3 year period.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.